Yahoo
NasdaqGS - Delayed Quote USD

Clover Health Investments, Corp. (CLOV)

5.41 +0.20 (+3.84%)
At close: June 26 at 4:00:01 PM EDT
5.39 -0.02 (-0.37%)
After hours: June 26 at 7:58:59 PM EDT
Trade CLOV on Coinbase
Chart Range Bar
Loading chart for CLOV

News headlines Clover Health (CLOV) is gaining attention due to a significant 31.2% revenue growthand a recent 4.5-star ratingfrom CMS, boosting investor sentiment. Analysts note its positive cash flow and growth potential, but caution remains regarding profitability and competition in the healthcare sector.

Clover Health (CLOV) is gaining attention due to a significant 31.2% revenue growthand a recent 4.5-star ratingfrom CMS, boosting investor sentiment. Analysts note its positive cash flow and growth potential, but caution remains regarding profitability and competition in the healthcare sector.

Updated 40m ago · Powered by Yahoo Scout
  • Previous Close 5.21
  • Open 5.21
  • Bid 3.91 x 100
  • Ask 6.65 x 100
  • Day's Range 5.18 - 5.49
  • 52 Week Range 1.58 - 5.49
  • Volume 15,084,536
  • Avg. Volume 7,640,472
  • Market Cap (intraday) 2.849B
  • Beta (5Y Monthly) 2.48
  • PE Ratio (TTM) --
  • EPS (TTM) -0.12
  • Earnings Date (est.) Aug 4, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 4.15

Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware.

www.cloverhealth.com

724

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Healthcare Plans

Industry

Performance Overview

Trailing total returns as of 6/26/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

CLOV
130.21%
S&P 500 (^GSPC)
7.43%

1-Year Return

CLOV
93.91%
S&P 500 (^GSPC)
19.75%

3-Year Return

CLOV
534.23%
S&P 500 (^GSPC)
69.89%

5-Year Return

CLOV
58.29%
S&P 500 (^GSPC)
71.79%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 749.19M
Earnings 39.74M

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

0
200M
400M
600M

Analyst Insights

View More

Analyst Price Targets

3.50 Low
4.15 Average
5.41 Current
4.75

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 6/11/2026
Analyst UBS
Rating Action Maintains
Rating Neutral
Price Action Raises
Price Target 2.75 -> 4.75

Statistics

View More

Valuation Measures

Annual
As of 6/26/2026
  • Market Cap

    2.85B

  • Enterprise Value

    2.52B

  • Trailing P/E

    --

  • Forward P/E

    81.97

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.27

  • Price/Book (mrq)

    8.39

  • Enterprise Value/Revenue

    1.14

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -2.58%

  • Return on Assets (ttm)

    -5.55%

  • Return on Equity (ttm)

    -16.86%

  • Revenue (ttm)

    2.21B

  • Net Income Avi to Common (ttm)

    -56.94M

  • Diluted EPS (ttm)

    -0.12

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    203.54M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    75.08M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

5.41 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: